Deals
Aspen CEO Sees China Overtaking S. Africa as Biggest Market
- Infant-milk formula is among Aspen’s Chinese opportunities
- Aspen expanding in therapeutics from generic medicines
Stephen Saad
Photographer: Waldo Swiegers/BloombergThis article is for subscribers only.
Aspen Pharmacare Holdings Ltd. sees China eventually overtaking South Africa as its biggest market as the company completes its transition to a global therapeutics business from an Africa-focused generic-drugs maker.
The business sells medicines in more than 150 countries and is looking for partners as it expands in China, the Middle East and the U.S. The infant-milk formula market is just one area that represents a good opportunity in Asia’s most populous nation as the market consolidates, Chief Executive Officer Stephen Saad said.